Skip to main content
logo
Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
14.07
+0.39 (2.85%)
At close: May 27, 2026, 4:00 PM EDT
14.05
-0.02 (-0.14%)
After-hours: May 27, 2026, 7:32 PM EDT

Amylyx Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,5641,3272599972,458-
Market Cap Growth
280.69%411.68%-73.97%-59.45%--
Enterprise Value
1,2901,01583.38627.272,1150
Last Close Price
14.0712.083.7814.7236.95-
PE Ratio
---21.03--
Forward PE
---16.68--
PS Ratio
--2.972.62110.55-
PB Ratio
5.724.351.572.307.22-
P/TBV Ratio
5.193.741.562.386.35-
P/FCF Ratio
---93.34--
P/OCF Ratio
---83.62--
EV/Sales Ratio
--0.951.6595.14-
EV/EBITDA Ratio
---15.73--
EV/EBIT Ratio
---16.17--
EV/FCF Ratio
---58.74--
Debt / Equity Ratio
0.020.020.000.000.010
Debt / EBITDA Ratio
---0.11--
Debt / FCF Ratio
---0.40--
Net Debt / Equity Ratio
-1.00-1.02-1.06-0.85-1.000.64
Net Debt / EBITDA Ratio
1.732.040.56-9.201.701.16
Net Debt / FCF Ratio
2.272.521.04-34.381.871.28
Asset Turnover
-00.250.840.090.00
Inventory Turnover
--6.501.060.61-
Quick Ratio
17.5213.986.235.017.775.53
Current Ratio
17.8514.276.675.668.206.03
Return on Equity (ROE)
-51.90%-61.59%-100.88%12.73%-92.53%-188.05%
Return on Assets (ROA)
-50.89%-58.27%-88.41%7.75%-81.33%-138.14%
Return on Invested Capital (ROIC)
4728.75%1976.28%-1111.62%106.30%5078.00%1181.34%
Return on Capital Employed (ROCE)
-54.21%-64.52%-104.80%9.95%-92.98%-174.09%
Earnings Yield
---4.76%--
FCF Yield
---1.07%--
Buyback Yield / Dilution
-38.81%-38.78%2.64%-19.65%-788.13%0.00%
Total Shareholder Return
-38.81%-38.78%2.64%-19.65%-788.13%0.00%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q